Leaflet NOVOMIX 70 PENFILL 100U / ml injection suspension in cartridge
Indicated for: diabetes mellitus
Substance: insulin aspart (insulin)
ATC: A10AD05 (Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting)
Insulin aspart is a rapid-acting insulin analog used to control blood sugar levels in patients with type 1 and type 2 diabetes. It works quickly after administration, helping to reduce blood glucose levels after meals.
The medication is administered as a subcutaneous injection, usually before meals, as directed by a doctor. It is important for patients to regularly monitor blood sugar levels and adjust the dose as needed.
Patients should be aware of potential side effects, such as hypoglycemia, injection site reactions, or weight gain. It is important to inform the doctor of any unusual symptoms.
Common side effects include hypoglycemia, injection site reactions, and weight gain. In rare cases, severe allergic reactions may occur. Patients should be informed of these risks before use.
General data about NOVOMIX 70 PENFILL 100U / ml
- Substance: insulin aspart
- Date of last drug list: 01-07-2013
- Commercial code: W43550001
- Concentration: 100U / ml
- Pharmaceutical form: injection suspension in cartridge
- Packing volume: 3ml
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for insulin aspart
Concentrations available for insulin aspart
- 100U/ml
- 100UIml
